Notice of convening the Extraordinary General Meeting of Shareholders of BS Biotechna S.A.

Acting pursuant to Article 399 § 1 and 402 § 3 of the Commercial Companies Code [Kodeks Spółek Handlowych, “KSH”], I hereby notify you that the Management Board of the Company under the name BS Biotechna Spółka Akcyjna with its registered seat in Kraków, at ul. Szlak 77 lok. 222, 31-153 Kraków, entered into the Register of Entrepreneurs of the National Court Register maintained by the District Court for Kraków-Śródmieście in Kraków, 11th Commercial Division of the National Court Register under the KRS number: 0001002587, using the following numbers: REGON: 382882573, Tax Identification Number [Numer Identyfikacji Podatkowej, NIP]: 9452226486 (hereinafter referred to as the “Company”), convened the Extraordinary General Meeting of the Company on 26 November 2024, at 10.00 a.m., at the Regus Office, Conference Room, floor II, at ul. Grójecka 208 in Warsaw, with the following agenda:

1. Opening of the General Meeting of Shareholders of the Company.
2. Selecting the Chairperson of the General Meeting of Shareholders of the Company.
3. Drafting the attendance list of participants of the General Meeting of Shareholders of the Company.
4. Confirmation that the General Meeting of Shareholders of the Company has been properly convened and confirmation of its ability to pass resolutions.
5. Adopting the agenda.
6. Passing a resolution regarding granting approval for the acquisition of shares by the Company for the purpose of their redemption.
7. Passing a resolution regarding the appointment of a proxy pursuant to Article 379 § 1 of the Commercial Companies Code to conclude share purchase agreements for redemption with Company’s Management Board members.
8. Passing a resolution regarding the redemption of shares.
9. Passing a resolution regarding the reduction of the Company’s share capital with its simultaneous increase and exclusion of the pre-emptive right of the existing shareholders.
10. Passing a resolution regarding an increase of the Company’s share capital and excluding the pre-emptive right of existing shareholders.
11. Passing a resolution on amending the Company’s Articles of Association in terms of the Company’s name, share capital and authorized capital.
12. Other motions.
13. Closing the Meeting.